Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.

Cancer cell - 11 Jan 2021

Murciano-Goroff Yonina R, Drilon Alexander, Stadler Zsofia K

Abstract excerpt

The NCI-MATCH is a national master protocol trial, published in the Journal of Clinical Oncology, in which diverse tumors are sequenced and patients assigned to treatment. The trial demonstrates the feasibility of identifying rare and common actionable genetic alterations and underscores the strength of academic/community partnerships for improving trial access.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Feasibility Studies
Share to Interdisciplinary Communication

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Neoplasms

Share to Precision Medicine

Share to Rare Diseases

Share to Sample Size

Source

Open in PubMed Open full text

Identifiers

PMID: 33434511
DOI: 10.1016/j.ccell.2020.12.021
PMCID: PMC10640715

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The NCI-MATCH: A National, Collaborative Precision Oncology Trial for Diverse Tumor Histologies.PMID 33434511Read ↗

Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.Semantic proximity Read ↗

National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.Semantic proximity Read ↗

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications.Semantic proximity Read ↗

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapySemantic proximity Read ↗

Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy.Semantic proximity Read ↗

Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.Semantic proximity Read ↗

A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer.Semantic proximity Read ↗

The Future of Precision Oncology.Semantic proximity Read ↗

Precision oncology based on omics data: The NCT Heidelberg experienceSemantic proximity Read ↗

A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.Semantic proximity Read ↗

Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trialSemantic proximity Read ↗

From Tissue-Agnostic to N-of-One Therapies: (R)Evolution of the Precision Paradigm.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.